USBC, Inc. (USBC) - Total Liabilities

Latest as of December 2025: $12.14 Million USD

Based on the latest financial reports, USBC, Inc. (USBC) has total liabilities worth $12.14 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

USBC, Inc. - Total Liabilities Trend (2005–2025)

This chart illustrates how USBC, Inc.'s total liabilities have evolved over time, based on quarterly financial data. See USBC, Inc. (USBC) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

USBC, Inc. Competitors by Total Liabilities

The table below lists competitors of USBC, Inc. ranked by their total liabilities.

Company Country Total Liabilities
Assertio Therapeutics Inc
NASDAQ:ASRT
USA $135.67 Million
Leclanche SA
SW:LECN
Switzerland CHF166.92 Million
Terra Santa Propriedades Agrícolas S.A.
SA:LAND3
Brazil R$200.80 Million
Tofu Restaurant Co Ltd
TWO:2752
Taiwan NT$963.63 Million
Jagsonpal Pharmaceuticals Limited
NSE:JAGSNPHARM
India Rs461.88 Million
KOLIBRI GLOBAL ENERGY INC
F:B120
Germany €90.07 Million
First Capital Inc
NASDAQ:FCAP
USA $1.10 Billion
Axactor SE
OL:ACR
Norway Nkr930.72 Million

Liability Composition Analysis (2005–2025)

This chart breaks down USBC, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see USBC market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.13 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how USBC, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for USBC, Inc. (2005–2025)

The table below shows the annual total liabilities of USBC, Inc. from 2005 to 2025.

Year Total Liabilities Change
2025-09-30 $27.96 Million +380.36%
2024-09-30 $5.82 Million +28.72%
2023-09-30 $4.52 Million +16.07%
2022-09-30 $3.90 Million -66.55%
2021-09-30 $11.65 Million +76.55%
2020-09-30 $6.60 Million +11.12%
2019-09-30 $5.94 Million +26.03%
2018-09-30 $4.71 Million -8.52%
2017-09-30 $5.15 Million -5.35%
2016-09-30 $5.44 Million -30.60%
2015-09-30 $7.84 Million +18.24%
2014-09-30 $6.63 Million -10.26%
2013-09-30 $7.39 Million +44.35%
2012-09-30 $5.12 Million -12.97%
2011-09-30 $5.88 Million -1.93%
2010-09-30 $6.00 Million +335.01%
2009-09-30 $1.38 Million -35.49%
2008-09-30 $2.14 Million +36.34%
2007-09-30 $1.57 Million +1074.66%
2005-09-30 $133.41K --

About USBC, Inc.

NYSE MKT:USBC USA Scientific & Technical Instruments
Market Cap
$151.38 Million
Market Cap Rank
#17711 Global
#4111 in USA
Share Price
$0.39
Change (1 day)
-5.13%
52-Week Range
$0.31 - $1.35
All Time High
$1.35
About

USBC, Inc., together with its subsidiaries, operates in digital financial technologies business in United States. The company develops transformative financial services, including digital assets, banking solutions, and non-invasive health monitoring research. It serves retail users, fintech partners, and institutional counterparties. The company was formerly known as Know Labs, Inc. and changed i… Read more